Circulating Dipeptidyl Peptidase 3 and Alteration in Haemodynamics in Cardiogenic Shock: Results from the OptimaCC Trial
Koji Takagi(Momentum Research), Antoine Kimmoun(Imation (United States)), Oliver Hartmann, Fériel Azibani(Inserm), Karine Santos(Radboud University Nijmegen), Andreas Bergmann(Agostino Gemelli University Polyclinic), Bruno Lévy(Centre Hospitalier Régional et Universitaire de Nancy), Étienne Gayat(Inserm), Elodie Féliot(Inserm), Benjamin Deniau(Inserm), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Alice Blet(Inserm)
Cited by 97
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Journal of Heart Failure|2022|2.1k